OGN vs SONM · P/E 3.4, rev $6.40B vs rev $58.3M
Organon & Co (OGN) versus Sonim Technologies Inc (SONM) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Sonim Technologies Inc (SONM) is a software - infrastructure company listed on NASDAQ.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SONM revenue for 2024-12-31 was $58.3M. Net income was -$33.6M. SONM currently screens at market cap $7.0M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SONM currently screens at market cap $7.0M.
Not investment advice. Open the OGN and SONM stock pages for the full models.
Not investment advice.